Illegal PIP silicone biocompatibility test results expected in May
This article was originally published in Clinica
The biocompatibility tests being conducted on the illegal silicone filler of breast implants made by Poly Implant Prothèse (PIP) are expected to be completed next month, French healthcare regulatory authority Afssaps has told Clinica. There is no specific scheduled date for their publication, the spokesperson added. No further information is yet available on the total number of implants affected internationally, ie all those produced by the La Seyne-sur-Mer, Provence manufacturer since 2001.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.